Get started
[PAH] Porsche Holding SE | 2025 Update - Entry rejectedHello, quick update on the potential reversal trade for : Assuming that the fundamentals were checked and the Idea was to be contrarian to the overall negative sentiment towards Porsche Holding SE: ***Info to the video and the comment on the Euro-Dollar : First thing coming to mind is that, Porsche 'would profit' as an exporteur from a declining Euro. However, Porsche Holding SE as a german car manufacturer is affected from the same negative fundamentals (i.e. difficult success to energy, inflation of raw materials, rekt consumer...) that are leading to a certain decline of its native currency. More on that in my idea.
XETR:PAH3Short
by OiconomiX_io
Bayer stock : Contrarian storyBayer stock might be considered a contrarian investment: Legal overhang from Monsanto acquisition: The ongoing litigation related to the Roundup herbicide has created significant uncertainty and negatively impacted Bayer's stock price. A contrarian investor might see this as an overreaction and believe the company's long-term value will prevail. Undervalued compared to peers: Some analysts believe Bayer is undervalued compared to its competitors in the pharmaceutical and agricultural industries. This could present an opportunity for contrarian investors who believe the market has overcorrected. Potential for turnaround: Bayer has faced challenges in recent years, but the company is taking steps to address its issues, including restructuring and focusing on innovation. A contrarian investor might bet on the success of these efforts and a future rebound in the stock price. Risks to consider: Uncertainty about the outcome of the Roundup litigation: The potential financial impact of ongoing and future lawsuits remains a significant risk for Bayer. Challenges in the pharmaceutical and agricultural industries: Bayer faces competition and other challenges in its core business segments. Execution risk: There's no guarantee that Bayer's restructuring and innovation efforts will be successful.
XETR:BAYNLong
by StockBlog
SAPSAP - Monthly from the beginning year 94 - Strong uptrend since '22. A few companies determine the performance of the German DAX. One of these "tanks" is SAP. The chart seems to be on its way to 310.80 EUR per share, a Fibonacci-Extension in green. This level represents the end of Cycle wave III in green. After that the chart should form in three waves a 23.6-% correction in total as a flat. In the chart you see the volume which is decreasing over a long time period. So the actually reached higher highs are formed with lower and lower volume. Furthermore, the MACD is mentioned. This index forms typical negative values within a wave 2 which is an ABC-correction of the direction of the trend wave. Its extreme value reaches the MACD always in the C-wave of the ABC-correction. Look in the chart, please. There are two results.
XETR:SAPLong
by armandogui
Bayer AG Analysis: Growth Potential and Positive Buying SentimenThe history of Bayer AG shares goes through many key moments and events: Foundation and early years: Bayer was founded in 1863 by Friedrich Bayer and Johann Wagner in Germany. The company initially dealt with the production of chemicals and textile dyes. Development of aspirin: In 1897, Bayer synthesized aspirin, which became one of the most recognizable drugs in the world. This is considered one of the key moments that established the profile of the company. World War I: During World War I, most of Bayer's assets were confiscated by the Allies, and the company was forced to reorganize. World War II and post-war period: Bayer, like many German companies, went through significant changes after World War II. A few years later, Bayer joined the newly formed chemical group "Fritz Haber" and focused on innovation. Diversification and Growth: In the 1970s and 1980s, the company began to diversify into areas such as pharmaceuticals, agronomy, and biotechnology. Acquisitions and New Products: Bayer AG acquired companies that strengthened its portfolio, including Monsanto in 2018, which provided significant advances in agronomy. Recent Challenges: In recent years, the company has faced legal challenges and disputes related to its products, particularly glyphosate, the active ingredient in Roundup. Key Points Oakmark International fund manager David Herro sees growth potential for Bayer. The company's agricultural cycle is showing signs of bottoming out. Bayer AG operates in three main segments: Crop Science, Pharmaceuticals, and Consumer Health. The Crop Science segment focuses on sustainable agriculture through seeds and crop protection. The Pharmaceuticals segment offers prescription products, particularly in the areas of cardiology and women's health. The Consumer Health segment includes nonsteroidal dermatology products and health supplements.
XETR:BAYNLong
by ForexCompany
Porsche is a hot topic for investors in 2025Porsche is a hot topic for investors in 2025, trading near historic lows. Barclays recently upgraded the stock to Overweight with a price target of €70, saying the current price could represent a good opportunity for long-term investors. Despite a 15% decline in the past month, earnings growth expectations for 2025 and 2026 remain above 10% per year, despite doubts about volume and margin targets. TRADINGVIEW INVESTING.COM Key risks include the company’s reliance on the U.S. and Chinese markets, as well as the impact of tariffs. However, the positive outlook for electric vehicles and Porsche’s luxury segment is keeping the stock attractive.
GETTEX:PAH3Long
by ForexCompany
2
The only direction is up.Sometimes, you can enter a trade without an overarching structure or a correction level guiding the direction. This is a prime example. After an intriguing sideways movement, marked by almost textbook ups and downs, we saw the range break briefly to the downside—a classic range spike, or as some call it, a fakeout. This fakeout has trapped short-sellers, and as their positions get liquidated, they’ll fuel upward momentum. Interestingly, the range spike ended precisely at the resistance line of our broader structure, highlighted in red. Given this, I don’t expect us to revisit the target level, and the structure is effectively complete. This is an ideal spot for a long position. Even without bullish structures forming, the chart has only one direction to go from here—up and to the right.
XETR:TKALong
by xSamu_TA